logo
Plus   Neg
Share
Email

A.O. Smith Slashes FY19 Adj. EPS Outlook - Quick Facts

While reporting financial results for the third quarter on Tuesday, A.O. Smith Corp. (AOS) slashed its adjusted earnings outlook for the full-year 2019, reflecting a projected decline in China sales.

For fiscal 2019, the company slashed its adjusted earnings guidance to a range of $2.25 to $2.28 per share from the prior range of $2.35 to $2.41 per share.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.35 per share for the year. Analysts' estimates typically exclude special items.

The company also said it projects full year China sales to decline 19 percent in local currency and 23 percent in U.S. dollars.

Previously, the company expected full year China sales to be down between 16 and 17 percent year-over-year in local currency terms and 19 and 20 percent after a three percentage point currency headwind.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration is hastening its efforts to make available more at-home testing options in response to the ongoing COVID-19 pandemic. All At-Home Covid-19 Tests being used now are authorized only for emergency use, and not cleared or fully approved by the FDA. The recent granting of EUA for the Quidel Corp.'s QuickVue At-Home COVID-19 Test is one example. Dollar Tree Inc. (DLTR) Wednesday reported a profit for the fourth-quarter that climbed 309 percent from last year, while Wendy's Co. (WEN) posted a profit that grew about 46.0 percent from the prior year. Dollar Tree has increased its share repurchase authorization by $2.0 billion. Wendy's expects profit for fiscal year 2021 to be below analysts' expectations. Medical devices company Boston Scientific Corp. (BSX) agreed Wednesday to acquire the global surgical business of Israel-based Lumenis LTD from an affiliate of Baring Private Equity Asia (BPEA) for an upfront cash payment of $1.07 billion, subject to closing adjustments. Lumenis is a privately-held...
Follow RTT